S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
NASDAQ:AEMD

Aethlon Medical (AEMD) Stock Price, News & Analysis

$1.70
-0.01 (-0.58%)
(As of 02/23/2024 ET)
Today's Range
$1.63
$1.74
50-Day Range
$1.64
$2.19
52-Week Range
$1.40
$7.20
Volume
3,334 shs
Average Volume
6,382 shs
Market Capitalization
$4.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

Aethlon Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,252.9% Upside
$23.00 Price Target
Short Interest
Healthy
0.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Aethlon Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($4.98) to ($5.27) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.61 out of 5 stars


AEMD stock logo

About Aethlon Medical Stock (NASDAQ:AEMD)

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

AEMD Stock Price History

AEMD Stock News Headlines

My wife was skeptical... until I showed her my account balance.
The Fed just created the single greatest income opportunity I've seen in nearly 20 years. I've put more than $1M of my own money into it. And plan to add another million! I even suggested my wife put her savings into it.    
My wife was skeptical... until I showed her my account balance.
The Fed just created the single greatest income opportunity I've seen in nearly 20 years. I've put more than $1M of my own money into it. And plan to add another million! I even suggested my wife put her savings into it.    
Aethlon Medical Q3 2024 Earnings Preview
Earnings Preview: Aethlon Medical
Maxim Group Keeps Their Hold Rating on Aethlon Medical (AEMD)
A Preview Of Aethlon Medical's Earnings
Aethlon Medical Inc AEMD
See More Headlines
Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2023
Today
2/25/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
6/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:AEMD
Fax
N/A
Employees
15
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+1,252.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-12,030,000.00
Pretax Margin
-2,133.97%

Debt

Sales & Book Value

Annual Sales
$570,000.00
Book Value
$2.90 per share

Miscellaneous

Free Float
2,515,000
Market Cap
$4.45 million
Optionable
Optionable
Beta
1.88
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Guy F. Cipriani BS (Eng.) (Age 54)
    MBA, Chief Operating Officer
    Comp: $347.5k
  • Dr. Steven P. LaRosa M.D. (Age 57)
    Chief Medical Officer
    Comp: $430k
  • Mr. James B. Frakes M.B.A. (Age 67)
    Interim CEO, CFO, Secretary & Director
    Comp: $385k
  • Dr. Lee D. Arnold Ph.D. (Age 64)
    Chief Scientific Officer














AEMD Stock Analysis - Frequently Asked Questions

Should I buy or sell Aethlon Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AEMD shares.
View AEMD analyst ratings
or view top-rated stocks.

What is Aethlon Medical's stock price target for 2024?

1 equities research analysts have issued twelve-month price objectives for Aethlon Medical's shares. Their AEMD share price targets range from $23.00 to $23.00. On average, they anticipate the company's share price to reach $23.00 in the next twelve months. This suggests a possible upside of 1,252.9% from the stock's current price.
View analysts price targets for AEMD
or view top-rated stocks among Wall Street analysts.

How have AEMD shares performed in 2024?

Aethlon Medical's stock was trading at $2.19 at the beginning of the year. Since then, AEMD stock has decreased by 22.4% and is now trading at $1.70.
View the best growth stocks for 2024 here
.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a decline in short interest in January. As of January 31st, there was short interest totaling 7,600 shares, a decline of 24.8% from the January 15th total of 10,100 shares. Based on an average daily trading volume, of 17,300 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.3% of the company's stock are sold short.
View Aethlon Medical's Short Interest
.

When is Aethlon Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 26th 2024.
View our AEMD earnings forecast
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Thursday, August, 10th. The medical equipment provider reported ($1.30) earnings per share for the quarter, missing analysts' consensus estimates of ($1.20) by $0.10. During the same quarter in the previous year, the firm earned ($1.90) earnings per share.

When did Aethlon Medical's stock split?

Aethlon Medical shares reverse split on the morning of Thursday, October 5th 2023. The 1-10 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), Organigram (OGI), AT&T (T) and

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (0.85%), Concourse Financial Group Securities Inc. (0.00%) and Simplex Trading LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AEMD) was last updated on 2/25/2024 by MarketBeat.com Staff